Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.98.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.34.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.124.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.203EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.8.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.7.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.254EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.36.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.79 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.209EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.236EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.395EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.120.2.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.416.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.532EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.408EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.42.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.348EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.243.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.98EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.566EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.480EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.579EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.11 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.435EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.445EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.124EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.384EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.569EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used